Teva writes off $4.6b for litigation uncertainties - Globes
David M. Stark - Group EVP, Chief Legal Officer - Teva Pharmaceuticals | LinkedIn
On notice: Teva's entire $330m legal spend could go to one law firm – GC Magazine
Pending litigation weighs on Teva | Financial Times
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
/cloudfront-us-east-2.images.arcpublishing.com/reuters/G5JWOXLOQZIDLHFUUAR3HXPXEQ.jpg "Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters")
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Teva Announces Appointment of New Global R&D and Chief Medical Officer | Business Wire
Four key relationships at the heart of Teva's pharmaceutical trademark management – exclusive interview - World Trademark Review
Buyers remorse or fraud? Teva and Mexican brothers slug it out over sour deal
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LZGVDDQWGFNKPLS2GEX4W3DBA4.jpg "Teva lied about opioid role, New York says | Reuters")
Teva lied about opioid role, New York says | Reuters
Blues plan sues Teva over marketing for its MS drug Copaxone
Trouble at Teva: US price-fixing lawsuit adds to generic giant's woes - Pharma Technology Focus | Issue 85 | August 2019
On notice: Teva's entire $330m legal spend could go to one law firm – GC Magazine
Teva Chief Legal Officer Seeks to Reduce Outside Counsel Spend | Corporate Counsel
David Stark — Group EVP, Chief Legal Officer at Teva Pharmaceuticals | Comparably
Teva Chief Legal Officer Seeks to Reduce Outside Counsel Spend | Corporate Counsel
takertua liitutaulu syvällinen syrjäytyminen Armoilla upseeri teva legal team - buckfast.fi
Teva Pharmaceuticals Executive Team | Comparably
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Teva to pay $85m to Oklahoma over opioid case | Financial Times
Idea of the Week: Teva Pharmaceutical—The Top Leader in Generic Drugs | Bondsupermart
Teva's new CEO shakes up management, to combine divisions | Reuters
Teva Pharmaceuticals Executive Team | Comparably
On notice: Teva's entire $330m legal spend could go to one law firm – GC Magazine
Teva Announces New Org Structure, Leadership Changes | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Karen Bechtold – Teva Pharmaceuticals - Vanguard Law Magazine
